118 related articles for article (PubMed ID: 6249065)
1. Cell-mediated immunity to herpes virus type-1 in patients with recurrent corneal herpes simplex.
Hammer H; Dobozy A
Acta Ophthalmol (Copenh); 1980 Apr; 58(2):161-6. PubMed ID: 6249065
[TBL] [Abstract][Full Text] [Related]
2. Leukocyte migration inhibitory factor in HSV infections.
Centifanto YM; Zam ZS; McNeill JI; Kaufman HE
Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):863-8. PubMed ID: 212384
[TBL] [Abstract][Full Text] [Related]
3. Cellular immunity and circulating antibody to herpes simplex virus in subjects with recurrent herpex simplex lesions and controls as measured by the mixed leukocyte migration inhibition test and complement fixation.
Gange RW; de Bats A; Park JR; Bradstreet CM; Rhodes EL
Br J Dermatol; 1975 Nov; 93(5):539-44. PubMed ID: 173386
[TBL] [Abstract][Full Text] [Related]
4. Cell-mediated immunity in herpetic keratitis measured by leukocyte migration inhibition.
Polack FM; Habash N; Zam ZS; Burdette MG
Ann Ophthalmol; 1982 Sep; 14(9):825-7. PubMed ID: 6295252
[TBL] [Abstract][Full Text] [Related]
5. Induction of cell-mediated immunity in herpes simplex virus keratitis. Kinetics of lymphocyte transformation and the effect of antiviral antibody.
Meyers-Elliott RH; Chitjian PA
Invest Ophthalmol Vis Sci; 1980 Aug; 19(8):920-9. PubMed ID: 6250986
[TBL] [Abstract][Full Text] [Related]
6. Immunology of herpesvirus infection: immunity to herpes simplex virus in eye infections.
Meyers RL; Chitjian PA
Surv Ophthalmol; 1976; 21(2):194-204. PubMed ID: 185741
[TBL] [Abstract][Full Text] [Related]
7. Cell mediated immunity to herpes simplex in man. IV. A correlation of lymphocyte stimulation and inhibition of leukocyte migration.
Russell AS; Kaiser J; Lao VS
J Immunol Methods; 1976; 9(3-4):273-9. PubMed ID: 175120
[TBL] [Abstract][Full Text] [Related]
8. Lysis of herpes simplex virus (HSV) infected targets. I. A comparison of the activity of lymphocytes from patients with HSV recurrences at different anatomical sites.
Hendricks RL; Sugar J
Curr Eye Res; 1984 Mar; 3(3):473-80. PubMed ID: 6321105
[TBL] [Abstract][Full Text] [Related]
9. Infection with herpes simplex virus and cell-mediated immunity after marrow transplant.
Meyers JD; Flournoy N; Thomas ED
J Infect Dis; 1980 Sep; 142(3):338-46. PubMed ID: 6255035
[TBL] [Abstract][Full Text] [Related]
10. [Specific and unspecific immune stimulation in recurrent herpes simplex].
Raab W
Z Hautkr; 1977 May; 52(10):565-72. PubMed ID: 195407
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte migration inhibitory factor in primary and recurrent ocular infections by herpes simplex-virus.
Grabner G; Jarisch R
Albrecht Von Graefes Arch Klin Exp Ophthalmol; 1979 Jul; 211(1):85-93. PubMed ID: 313723
[TBL] [Abstract][Full Text] [Related]
12. [Effect of the herpes simplex virus antigen on E rosette formation by the lymphocytes of patients with ocular herpes].
Maĭchuk IuF; Mikuli SG
Vopr Virusol; 1985; 30(1):78-80. PubMed ID: 2986358
[TBL] [Abstract][Full Text] [Related]
13. Experimental ulcerative herpetic keratitis. IV. Preliminary observations on the efficacy of a herpes simplex subunit vaccine.
Carter CA; Hartley CE; Skinner GR; Turner SP; Easty DL
Br J Ophthalmol; 1981 Oct; 65(10):679-82. PubMed ID: 6274376
[TBL] [Abstract][Full Text] [Related]
14. [The lymphocyte transformation test in patients with recurrent herpes simplex diseases (author's transl)].
Wassilew SW; Koch I
Arch Dermatol Res; 1978 Aug; 262(3):267-74. PubMed ID: 214045
[TBL] [Abstract][Full Text] [Related]
15. Cellular neuroimmunologic responses to ocular herpes simplex virus infection.
Gebhardt BM; Hill JM
J Neuroimmunol; 1990 Aug; 28(3):227-36. PubMed ID: 2165077
[TBL] [Abstract][Full Text] [Related]
16. Immunity to herpes simplex virus type 2. V. Risk of recurrent disease following primary infection: modulation of T-cell subsets and lymphokine (LIF) production.
Sheridan JF; Aurelian L
Diagn Immunol; 1983; 1(3):245-56. PubMed ID: 6209056
[TBL] [Abstract][Full Text] [Related]
17. Endogenously produced interferon alpha protects mice from herpes simplex virus type 1 corneal disease.
Hendricks RL; Weber PC; Taylor JL; Koumbis A; Tumpey TM; Glorioso JC
J Gen Virol; 1991 Jul; 72 ( Pt 7)():1601-10. PubMed ID: 1649898
[TBL] [Abstract][Full Text] [Related]
18. Immunology of herpes simplex virus in fection.
Meyers RL
Int Ophthalmol Clin; 1975; 15(4):37-47. PubMed ID: 178622
[TBL] [Abstract][Full Text] [Related]
19. Cell-mediated immunity in herpes corneal stromal disease.
Nagy RM; McFall RC; Sery TW
Invest Ophthalmol Vis Sci; 1980 Mar; 19(3):271-7. PubMed ID: 6965667
[TBL] [Abstract][Full Text] [Related]
20. Herpes simplex virus--induced destructive corneal disease.
Foster CS
Eye (Lond); 1989; 3 ( Pt 2)():194-203. PubMed ID: 2559859
[No Abstract] [Full Text] [Related]
[Next] [New Search]
